Israel Englander Karuna Therapeutics, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$161.01 - $317.85 $1.39 Million - $2.74 Million	8,613 Added 5.58%	162,991 $51.6 Million
Q2 2023 Aug 14, 2023	BUY	$176.32 - $240.22 $27.2 Million - $37.1 Million	154,378 New	154,378 $33.5 Million
Q4 2022 Feb 14, 2023	SELL	$191.53 - $236.82 $7.88 Million - $9.74 Million	-41,127 Reduced 73.72%	14,660 $2.88 Million
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $6.08 Million - $13.6 Million	49,108 Added 735.26%	55,787 $12.5 Million
Q2 2022 Aug 15, 2022	BUY	$93.97 - $143.33 $251,839 - $384,124	2,680 Added 67.02%	6,679 $845,000
Q1 2022 May 16, 2022	SELL	$98.9 - $132.37 $669,256 - $895,747	-6,767 Reduced 62.86%	3,999 $507,000
Q4 2021 Feb 14, 2022	SELL	$110.64 - $159.4 $1.28 Million - $1.85 Million	-11,582 Reduced 51.83%	10,766 $1.41 Million
Q3 2021 Nov 15, 2021	BUY	$101.2 - $125.87 $2.26 Million - $2.81 Million	22,348 New	22,348 $2.73 Million
Q2 2021 Aug 16, 2021	SELL	$107.45 - $135.95 $337,070 - $426,475	-3,137 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$95.46 - $133.08 $5.12 Million - $7.14 Million	-53,670 Reduced 94.48%	3,137 $377,000
Q4 2020 Feb 16, 2021	BUY	$75.23 - $109.23 $822,640 - $1.19 Million	10,935 Added 23.84%	56,807 $5.77 Million
Q3 2020 Nov 16, 2020	BUY	$71.31 - $109.74 $2.44 Million - $3.76 Million	34,275 Added 295.55%	45,872 $3.55 Million
Q2 2020 Aug 14, 2020	BUY	$62.14 - $117.21 $720,637 - $1.36 Million	11,597 New	11,597 $1.29 Million
Q4 2019 Feb 14, 2020	SELL	$11.44 - $123.99 $427,833 - $4.64 Million	-37,398 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$16.05 - $27.35 $538,798 - $918,139	-33,570 Reduced 47.3%	37,398 $610,000
Q2 2019 Aug 14, 2019	BUY	$20.02 - $20.02 $1.42 Million - $1.42 Million	70,968 New	70,968 $1.42 Million

Others Institutions Holding KRTX

# of Institutions

Shares Held

332K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account